Delivery Order SPE2DB24D2205-SPE2DB25FDUWT

Award Date 12/2/24
Potential Completion Date 12/3/24
Potential Value $5.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDUWT
    Delivery Order

The federal contract award, valued at $5,833.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This delivery order contract, which is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, covers the supply of 4,566,582,419 units of Vyvanse 40 mg capsules. The contract has a completion date of December 3, 2024 and uses a firm fixed-price pricing type. This contract award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen, a for-profit corporate entity, is a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, and has a significant role in supplying a wide range of pharmaceutical products and medical supplies to support the medical needs of the U.S. government and its beneficiaries.

Generated 3/3/25, 12:27 PM